U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
180991180991Olmesartan Medoxomil in AtherosclerosisCompletedNo Results AvailableEssential Hypertension|Atherosclerotic Cardiovascular DiseaseDrug: Olmesartan medoxomil|Drug: Atenolol|Drug: Hydrochlorothiazide|Drug: olmesartan medoxomil|Drug: atenololhttps://ClinicalTrials.gov/show/NCT00185185
180992180992Olmesartan in Essential HypertensionCompletedNo Results AvailableEssential HypertensionOther: placebo|Drug: olmesartan medoxomil|Drug: olmesartan medoxomil oral tablets, hydrochlorothiazide oral tabletshttps://ClinicalTrials.gov/show/NCT00185172
180993180993Olmesartan Medoxomil in Diabetes MellitusCompletedNo Results AvailableDiabetes Mellitus, Type 2|Cardiovascular Disease|Kidney DiseaseDrug: Olmesartan medoxomil|Drug: Placebo Tabletshttps://ClinicalTrials.gov/show/NCT00185159
180994180994Efficacy and Safety of Pactimibe in Patients With AtherosclerosisCompletedNo Results AvailableAtherosclerosisDrug: Pactimibehttps://ClinicalTrials.gov/show/NCT00185146
180995180995Study of co-Administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe HypertensionCompletedNo Results AvailableHypertensionDrug: Olmesartan medoxomil|Drug: Amlodipinehttps://ClinicalTrials.gov/show/NCT00185133
180996180996Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel BlockerCompletedNo Results AvailableHypertensionDrug: Olmesartan medoxomil|Drug: Hydroclorothiazide|Drug: Benazepril|Drug: Amlodipinehttps://ClinicalTrials.gov/show/NCT00185120
180997180997Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High CholesterolCompletedNo Results AvailableHypercholesterolemiaDrug: Colesevelam Hydrochloride|Drug: Ezetimibe|Drug: Simvastatinhttps://ClinicalTrials.gov/show/NCT00185107
180998180998A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to InsulinCompletedNo Results AvailableHypertension|Insulin Resistance|Metabolic SyndromeDrug: Olmesartan medoxomil|Drug: Losartan potassium|Drug: Atenololhttps://ClinicalTrials.gov/show/NCT00185094
180999180999Imaging Colo-Rectal Cancer Using a Two Step Antibody Technique in Nuclear ImagingRecruitingNo Results AvailableColonic NeoplasmsDrug: Indium labeled IMP-205xm734https://ClinicalTrials.gov/show/NCT00185081
181000181000An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With HypertensionCompletedNo Results AvailableHypertensionDrug: Olmesartan medoxomil|Drug: Olmesartan medoxomil/hydrochlorothiazide|Drug: Hydrochlorothiazidehttps://ClinicalTrials.gov/show/NCT00185068
181001181001The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy SubjectsCompletedNo Results AvailableHealthyDrug: Olmesartan medoxomil|Drug: Irbesartan|Drug: Valsartanhttps://ClinicalTrials.gov/show/NCT00185055
181002181002Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery DiseaseCompletedNo Results AvailableCoronary Heart DiseaseDrug: Pactimibe, CS-505https://ClinicalTrials.gov/show/NCT00185042
181003181003MR-Lymphography and Lymph Node Staging in Prostate CancerActive, not recruitingNo Results AvailableProstatic Neoplasms|Lymphatic MetastasisProcedure: Ferumoxtran-10 enhanced MRI (MRL)https://ClinicalTrials.gov/show/NCT00185029
181004181004Women Abuse and the Role of the Family Doctor.TerminatedNo Results AvailableImproved Recognition of Partner Abuse|Gender Differences in Discussing Partner Abuse|Abused Women's Expectations,Experiences|Abused Women's Health Care UtilisationBehavioral: a training to improve recognition of partner abuse.https://ClinicalTrials.gov/show/NCT00185016
181005181005Blockade of Vascular Potassium Channels During Human EndotoxemiaCompletedNo Results AvailableEndotoxemiaDrug: endotoxin|Drug: Potassium channel blockers: TEA, Quinin, Tolbutamide|Drug: L-NMMAhttps://ClinicalTrials.gov/show/NCT00185003
181006181006Effect of Selective iNOS Inhibition During Human EndotoxemiaCompletedNo Results AvailableEndotoxemiaDrug: Aminoguanidine|Drug: endotoxinhttps://ClinicalTrials.gov/show/NCT00184990
181007181007COPD on Primary Care Treatment (COOPT)CompletedNo Results AvailablePulmonary Disease, Chronic Obstructive|Lung Diseases, Obstructive|Bronchitis, ChronicDrug: N-acetylcysteine|Drug: fluticasone propionatehttps://ClinicalTrials.gov/show/NCT00184977
181008181008Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated AtelectasisRecruitingNo Results AvailableCarcinoma, Non Small Cell LungProcedure: CT-scan, PET-scanhttps://ClinicalTrials.gov/show/NCT00184964
181009181009Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV PatientsCompletedNo Results AvailableHIV Infections|HyperlipidemiaDrug: Rosuvastatinhttps://ClinicalTrials.gov/show/NCT00184951
181010181010Opioid Receptors Influence Ischemia-Reperfusion InjurySuspendedNo Results AvailableIschemia-Reperfusion InjuryDrug: morphine|Drug: naloxone|Drug: Technetium-TC99m-labeled Annexin A5|Procedure: forearm ischemic exercise|Procedure: ten minute forearm ischemiahttps://ClinicalTrials.gov/show/NCT00184938
181011181011Ventilator Associated Pneumonia and Late Complications of Percutaneous TracheostomyTerminatedNo Results AvailablePneumoniaProcedure: Tracheostomy|Device: cannula with subglottic drainagehttps://ClinicalTrials.gov/show/NCT00184925
181012181012The Effect of Caffeine on Ischemic PreconditioningCompletedNo Results AvailableCaffeine|Ischemic Preconditioning|Ischemia-Reperfusion InjuryDrug: caffeine|Drug: Technetium-TC99m-labeled Annexin A5|Procedure: ten minutes forearm ischemia|Procedure: ischemic forearm exercisehttps://ClinicalTrials.gov/show/NCT00184912
181013181013The Potential Role for Adenosine in the Haemodynamic Effects of Free Fatty AcidsCompletedNo Results AvailableObesity|Metabolic Syndrome XDrug: Intravenous infusion of Intralipid/heparin|Drug: Intravenous infusion of Glycerol/heparinhttps://ClinicalTrials.gov/show/NCT00184899
181014181014The Influence of Methotrexate on the Metabolism and Vascular Effects of Adenosine in HumansCompletedNo Results AvailableMethotrexate|VasodilationDrug: Methotrexate 15 mg/week for 12 weekshttps://ClinicalTrials.gov/show/NCT00184886
181015181015Legtest Multi Centre Testing of the Lively Legs Program for Promoting Compliance in Leg Ulcer PatientsCompletedNo Results AvailableLeg Ulcers|Varicose UlcersBehavioral: Health Counselinghttps://ClinicalTrials.gov/show/NCT00184873
181016181016The Role of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes of Head-and-Neck Cancer PatientsCompletedNo Results AvailableHead and Neck NeoplasmsProcedure: PET-scan, MRI-scanhttps://ClinicalTrials.gov/show/NCT00184860
181017181017Adenosine Receptors Influence Ischemia-Reperfusion InjurySuspendedNo Results AvailableIschemia-Reperfusion InjuryDrug: acetylcholine|Procedure: twenty minutes of forearm ischemia|Procedure: three 5-minute periods of forearm ischemia|Drug: adenosine|Drug: caffeinehttps://ClinicalTrials.gov/show/NCT00184847
181018181018Quality of Life and Liver MetastasesCompletedNo Results AvailableColorectal Liver Metastases|Quality of LifeBehavioral: quality of lifehttps://ClinicalTrials.gov/show/NCT00184834
181019181019Ischemic Injury and Ischemic Preconditioning in DiabetesCompletedNo Results AvailableDiabetes Mellitus, Insulin-Dependent|Ischemia-Reperfusion InjuryProcedure: Ischemic preconditioning|Procedure: Forearm ischemic exercise|Procedure: Annexin A5 scintigraphy|Drug: Diazoxide|Drug: glibenclamide|Drug: adenosinehttps://ClinicalTrials.gov/show/NCT00184821
181020181020Ambulatory Assessment of Motor State in Patients With Parkinson's Disease in Real Daily LifeRecruitingNo Results AvailableParkinson's Diseasehttps://ClinicalTrials.gov/show/NCT00184808

* Görseller ve İçerik tekif hakkına sahip olabilir